AAAAI & ACAAI GUIDELINES Bundle (free trial)

Chronic Rhinosinusitis with Nasal Polyps

AAAAI & ACAAI GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1512443

Contents of this Issue

Navigation

Page 7 of 7

1258 Upsala Rd Sanford, FL 32771 TEL: 407.878.7606 • FAX: 407.878.7611 Order additional copies at GuidelineCentral.com Copyright © 2023 All rights reserved AAAAICRS01233 Disclaimer is resource is for informational purposes only, intended as a quick-reference tool based on the cited source guideline(s), and should not be used as a substitute for the independent professional judgment of healthcare providers. Practice guidelines are unable to account for every individual variation among patients or take the place of clinician judgment, and the ultimate decision concerning the propriety of any course of conduct must be made by healthcare providers aer consideration of each individual patient situation. Guideline Central does not endorse any specific guideline(s) or guideline recommendations and has not independently verified the accuracy hereof. Any use of this resource or any other Guideline Central resources is strictly voluntary. Abbreviations AERD, aspirin (nonsteroidal anti-inflammatory) -exacerbated respiratory disease; ATAD, aspirin therapy aer desensitization; CRSwNP, chronic rhinosinusitis with nasal polyposis; CSU, chronic spontaneous urticaria; EDS, exhalation delivery system; GI, gastrointestinal; INCS, intranasal corticosteroid; JTFPP, Joint Task Force on Practice Parameters; NSAID, nonsteroidal anti-inflammatory drug ; OCS, oral corticosteroids; QoL, quality of life Source Rank MA, Chu DK, Bognanni A, Oykhman P, Bernstein JA, Ellis AK, Golden DBK, Greenhawt M, Horner CC, Ledford DK, Lieberman J, Luong AU, Orlandi RR, Samant SA, Shaker MS, Soler ZM, Stevens WW, Stukus DR, Wang J, Peters AT, e Joint Task Force on Practice Parameters GRADE Guidelines for the Medical Management of Chronic Rhinosinusitis with Nasal Polyposis, Journal of Allergy and Clinical Immunology (2022), doi: https://doi.org/10.1016/j.jaci.2022.10.026. Bognanni A, Chu DK, Rank MA, Bernstein J, Ellis AK, Golden D, Greenhawt M, Hagan JB, Horner CC, Ledford DK, Lieberman J, Luong AU, Marks LA, Orlandi RR, Samant SA, Shaker M, Soler ZM, Stevens WW, Stukus DR, Wang J, Peters AT. Topical corticosteroids for chronic rhinosinusitis with nasal polyposis: GRADE systematic review and network meta- analysis. J Allerg y Clin Immunol. 2022 Dec;150(6):1447-1459. Oykhman P, Paramo FA, Bousquet J, Kennedy DW, Brignardello-Petersen R, Chu DK. Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: A systematic review and network meta-analysis. J Allerg y Clin Immunol. 2022 Apr;149(4):1286-1295. Chu DK, Lee DS, Lee KM, Schunemann HJ, Szczeklik W, Lee JM. Benefits and harms of aspirin desensitization for aspirin exacerbated respiratory disease: a systematic review and meta-analysis. Int Forum Allerg y Rhin. 2019;9:1409-19.

Articles in this issue

Links on this page

Archives of this issue

view archives of AAAAI & ACAAI GUIDELINES Bundle (free trial) - Chronic Rhinosinusitis with Nasal Polyps